Zinpentraxin alfa

DB14852InvestigationalProtein Based Therapies

Zinpentraxin alfa is a recombinant form of PTX-2, a naturally circulating human protein. It is under investigation in clinical trial NCT01981850 (A Phase 2 Study Of PRM-151 In Subjects With...

Mechanism: Pharmacologically active on Serum amyloid P-component
Curator reviewed
Also known as: AMYLOID P COMPONENT, SERUM, RECOMBINANT · Recombinant human pentraxin-2 · RECOMBINANT HUMAN SERUM AMYLOID P · rhPTX-2 · Serum amyloid P protein (recombinant human PRM 151)
Code names: PRM-151 · RG-6354 · RO7490677

Resolves to

Compound

UNIIF68WAH6N5ECAS1387453-03-3

Targets

P02743APCS

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zinpentraxin alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account